{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:50:52Z","timestamp":1789541452253,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010485","name":"American Rhinologic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jaip.2022.02.017","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T11:32:30Z","timestamp":1645875150000},"page":"1454-1461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective"],"prefix":"10.1016","volume":"10","author":[{"given":"Rik J.L.","family":"van der Lans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie J.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sietze","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl S29","key":"10.1016\/j.jaip.2022.02.017_bib1","first-page":"1","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.02.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2022.02.017_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.017_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4193\/Rhin21.091","article-title":"Occupational exposure influences control of disease in patients with chronic rhinosinusitis","volume":"59","author":"Dietz de Loos","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib6","doi-asserted-by":"crossref","first-page":"734000","DOI":"10.3389\/falgy.2021.734000","article-title":"Therapeutic options for chronic rhinosinusitis in N-ERD patients","volume":"2","author":"van der Lans","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2022.02.017_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.02.017_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2020.10.043","volume":"147","author":"Stevens","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.017_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaci.2021.06.009","article-title":"Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease","volume":"148","author":"Cahill","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.017_bib10","first-page":"333","article-title":"The burden of non-steroidal anti-inflammatory exacerbated respiratory disease from the patient's perspective - a qualitative analysis of posts from the Samter's Society","volume":"58","author":"Alanin","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.017_bib12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.02.017_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.02.017_bib14","first-page":"151","article-title":"State-of-the-art overview on biological treatment for CRSwNP","volume":"59","author":"Hellings","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.017_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11882-020-00910-y","article-title":"A\u00a0critical look at the efficacy and costs of biologic therapy for chronic rhinosinusitis with nasal polyposis","volume":"20","author":"Brown","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.02.017_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0194599810391852","article-title":"Cost burden of chronic rhinosinusitis: a claims-based study","volume":"144","author":"Bhattacharyya","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.02.017_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of chronic rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.02.017_bib20","first-page":"1","article-title":"Summary health statistics for U.S. adults: National Health Interview Survey, 1997","volume":"10","author":"Blackwell","year":"2002","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jaip.2022.02.017_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhn.2002.129815","article-title":"Health care utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organization","volume":"127","author":"Murphy","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2022.02.017_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/000348941112000701","article-title":"Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States","volume":"120","author":"Bhattacharyya","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2022.02.017_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4193\/Rhin19.424","article-title":"The socioeconomic cost of chronic rhinosinusitis study","volume":"58","author":"Wahid","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/194589240301700106","article-title":"The economic burden and symptom manifestations of chronic rhinosinusitis","volume":"17","author":"Bhattacharyya","year":"2003","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2022.02.017_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2500\/ajra.2009.23.3355a","article-title":"Contemporary assessment of the disease burden of sinusitis","volume":"23","author":"Bhattacharyya","year":"2009","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2022.02.017_bib26","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/lary.24630","article-title":"Productivity costs in patients with refractory chronic rhinosinusitis","volume":"124","author":"Rudmik","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.02.017_bib27","first-page":"213","article-title":"Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps","volume":"58","author":"Lourijsen","year":"2020","journal-title":"Rhinology"},{"issue":"3 part 1","key":"10.1016\/j.jaip.2022.02.017_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0091-6749(99)70464-1","article-title":"Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders","volume":"103","author":"Ray","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.02.017_bib29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/lary.23943","article-title":"Health economic evaluation: important principles and methodology","volume":"123","author":"Rudmik","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.02.017_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2014explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jaip.2022.02.017_bib31","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/lary.28648","article-title":"Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"131","author":"Scangas","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2022.02.017_bib32","first-page":"277","article-title":"Does time from previous surgery predict subsequent treatment failure in chronic rhinosinusitis with nasal polyps?","volume":"59","author":"Hopkins","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib33","doi-asserted-by":"crossref","first-page":"190151","DOI":"10.1183\/16000617.0151-2019","article-title":"Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety","volume":"29","author":"Price","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2022.02.017_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/alr.22487","article-title":"Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors","volume":"10","author":"Loftus","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.02.017_bib35","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/alr.22865","article-title":"Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease","volume":"11","author":"Yong","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.02.017_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/all.15134","article-title":"Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"77","author":"Lans","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.02.017_bib37","first-page":"374","article-title":"The potential role of biological treatment of chronic rhinosinusitis with nasal polyps: a nationwide cohort study","volume":"59","author":"Eriksen","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2022.02.017_bib38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/coa.13779","article-title":"British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps","volume":"46","author":"Hopkins","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2022.02.017_bib39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/alr.22633","article-title":"Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop","volume":"10","author":"Roland","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2022.02.017_bib40","first-page":"81","article-title":"Predicting difficult-to-treat chronic rhinosinusitis by noninvasive biological markers","volume":"59","author":"Guo","year":"2021","journal-title":"Rhinology"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:31:40Z","timestamp":1761975100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2213219822002185"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.02.017","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}